Acadia Pharmaceuticals Inc financial data

Symbol
ACAD on Nasdaq
Location
12830 El Camino Real, Suite 400, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 259 % +16.6%
Quick Ratio 28.6 % +48.1%
Debt-to-equity 56.1 % -27.7%
Return On Equity 30.7 % +345%
Return On Assets 19.7 % +406%
Operating Margin -10.1 % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 169M shares +1.71%
Common Stock, Shares, Outstanding 169M shares +1.66%
Entity Public Float 2B USD -31%
Common Stock, Value, Issued 16K USD 0%
Weighted Average Number of Shares Outstanding, Basic 168M shares +1.38%
Weighted Average Number of Shares Outstanding, Diluted 169M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 726M USD +40.4%
Revenue from Contract with Customer, Excluding Assessed Tax 1.02B USD +14.4%
Research and Development Expense 324M USD -10%
Costs and Expenses 782M USD -9.87%
Operating Income (Loss) 237M USD +938%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 268M USD +486%
Income Tax Expense (Benefit) 45.7M USD +201%
Net Income (Loss) Attributable to Parent 222M USD +627%
Earnings Per Share, Basic 1 USD/shares +644%
Earnings Per Share, Diluted 1 USD/shares +639%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 254M USD +43.2%
Accounts Receivable, after Allowance for Credit Loss, Current 108M USD +3.67%
Inventory, Net 111M USD +28.4%
Assets, Current 961M USD +31.8%
Property, Plant and Equipment, Net 3.55M USD -14.4%
Operating Lease, Right-of-Use Asset 51M USD -2.67%
Other Assets, Noncurrent 2.25M USD +373%
Assets 1.23B USD +34.1%
Accounts Payable, Current 20.1M USD +1.08%
Employee-related Liabilities, Current 28.8M USD +10.5%
Accrued Liabilities, Current 310M USD -2.53%
Liabilities, Current 330M USD -2.32%
Deferred Income Tax Liabilities, Net 11.4M USD -7.83%
Operating Lease, Liability, Noncurrent 44.6M USD -5.48%
Other Liabilities, Noncurrent 28.5M USD +131%
Liabilities 403M USD +1.45%
Accumulated Other Comprehensive Income (Loss), Net of Tax 406K USD
Retained Earnings (Accumulated Deficit) -2.16B USD +9.33%
Stockholders' Equity Attributable to Parent 822M USD +59.2%
Liabilities and Equity 1.23B USD +34.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 20.3M USD -30.1%
Net Cash Provided by (Used in) Financing Activities 1.84M USD +76.2%
Net Cash Provided by (Used in) Investing Activities -124M USD -784%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 169M shares +1.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -102M USD -733%
Deferred Tax Assets, Valuation Allowance 455M USD -5.63%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 466M USD -5.68%
Operating Lease, Liability 56.3M USD -2.36%
Depreciation 229K USD -5.37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 223M USD +625%
Lessee, Operating Lease, Liability, to be Paid 63.9M USD -3.82%
Property, Plant and Equipment, Gross 14.4M USD +1.86%
Operating Lease, Liability, Current 11.7M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.7M USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.7M USD +7.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.62M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD +12.6%
Deferred Tax Assets, Operating Loss Carryforwards 117M USD -21.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 38.4M USD +3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.7M USD +12.7%
Operating Lease, Payments 11.1M USD +13.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.72M USD -48.5%
Deferred Tax Assets, Net of Valuation Allowance 8.7M USD +27.9%
Share-based Payment Arrangement, Expense 62.3M USD -6.96%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%